With A -17% Earnings Drop, Did Davide Campari-Milano S.p.A. (BIT:CPR) Really Underperform?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!
After reading Davide Campari-Milano S.p.A.'s (BIT:CPR) most recent earnings announcement (31 December 2018), I found it useful to look back at how the company has performed in the past and compare this against the latest numbers. As a long term investor, I pay close attention to earnings trend, rather than the figures published at one point in time. I also compare against an industry benchmark to check whether Davide Campari-Milano's performance has been impacted by industry movements. In this article I briefly touch on my key findings.
View our latest analysis for Davide Campari-Milano
How Well Did CPR Perform?
CPR's trailing twelve-month earnings (from 31 December 2018) of €296m has declined by -17% compared to the previous year.
Furthermore, this one-year growth rate has been lower than its average earnings growth rate over the past 5 years of 23%, indicating the rate at which CPR is growing has slowed down. Why could this be happening? Let's examine what's occurring with margins and whether the whole industry is feeling the heat.
In terms of returns from investment, Davide Campari-Milano has fallen short of achieving a 20% return on equity (ROE), recording 14% instead. However, its return on assets (ROA) of 7.0% exceeds the IT Beverage industry of 5.4%, indicating Davide Campari-Milano has used its assets more efficiently. And finally, its return on capital (ROC), which also accounts for Davide Campari-Milano’s debt level, has increased over the past 3 years from 10% to 11%. This correlates with a decrease in debt holding, with debt-to-equity ratio declining from 96% to 69% over the past 5 years.
What does this mean?
Though Davide Campari-Milano's past data is helpful, it is only one aspect of my investment thesis. Companies that are profitable, but have volatile earnings, can have many factors affecting its business. I suggest you continue to research Davide Campari-Milano to get a more holistic view of the stock by looking at:
Future Outlook: What are well-informed industry analysts predicting for CPR’s future growth? Take a look at our free research report of analyst consensus for CPR’s outlook.
Financial Health: Are CPR’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
NB: Figures in this article are calculated using data from the trailing twelve months from 31 December 2018. This may not be consistent with full year annual report figures.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.
